Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances

. 2018 ; 19 (2) : 91-98.

Jazyk angličtina Země Nizozemsko Médium print

Typ dokumentu dopisy

Perzistentní odkaz   https://www.medvik.cz/link/pmid29792142

BACKGROUND: The emergence of psychoactive designer drugs has significantly increased over the last few years. Customs officials are responsible for the control of products entering the European Union (EU) market. This control applies to chemicals in general, pharmaceutical products and medicines. Numerous products imported from non-EU countries, often declared as 'bath salts' or 'fertilizers', contain new psychoactive substance (NPS). REVIEW: These are not necessarily controlled under international law, but may be subject to monitoring in agreement with EU legislation. This situation imposes substantial challenges, for example, for the maintenance of spectral libraries used for their detection by designated laboratories. The chemical identification of new substances, with the use of powerful instrumentation, and the time needed for detailed analysis and interpretation of the results, demands considerable commitment. The EU Joint Research Centre endeavors to provide scientific support to EU Customs laboratories to facilitate rapid identification and characterisation of seized samples. In addition to analysing known NPS, several new chemical entities have also been identified. Frequently, these belong to NPS classes already notified to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) by the European Early- Warning System (EWS). CONCLUSION: The aim of this paper is to discuss the implementation of workflow mechanisms that are in place in order to facilitate the monitoring, communication and management of analytical data. The rapid dissemination of this information between control authorities strives to help protect EU citizens against the health risks posed by harmful substances.

Zobrazit více v PubMed

Brandt S.D., King L.A., Evans-Brown M. The new drug phenomenon: Editorial and perspective. Drug Test. Anal. 2014;6:587–597. PubMed

Dines A.M., Wood D.M., Yates C., Heyerdahl F., Hovda K.E., Giraudon I., Sedefov R., Dargan P.I., Euro-DEN Research Group Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months’ data collection from the european drug emergencies network (Euro-DEN). Clin. Toxicol. (Phila.) 2015;53:893–900. PubMed

Menzies E.L., Hudson S.C., Dargan P.I., Parkin M.C., Wood D.M., Kicman A.T. Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine: Identification of metabolites of methoxetamine using HRAM LCMS. Drug Test. Anal. 2014;6:506–515. PubMed

Bonnet U., Mahler H. Synthetic cannabinoids: Spread, addiction biology & current perspective of personal health hazard. Fortschr. Neurol. Psychiatr. 2015;83:221–231. PubMed

Erratico C., Negreira N., Norouzizadeh H., Covaci A., Neels H., Maudens K., van Nuijs A.L.N. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA. Drug Test. Anal. 2015;7:866–876. PubMed

Negreira N., Erratico C., Kosjek T., van Nuijs A.L.N., Heath E., Neels H., Covaci A. In vitro phase I and phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol. Anal. Bioanal. Chem. 2015;407:5803–5816. PubMed

Giné C.V., Espinosa I.F., Vilamala M.V. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Drug Test. Anal. 2014;6:819–824. PubMed

Cohen P.A., Travis J.C., Venhuis B.J. A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Test. Anal. 2014;6:805–807. PubMed

Adams A.J., Banister S.D., Irizarry L., Trecki J., Schwartz M., Gerona R. “Zombie” outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York. N. Engl. J. Med. 2017;376:235–242. PubMed

Ireland N.N. http://www.cbc.ca/news/health/fentanyl-carfentanil-opioid-crisis-spreading-across-canada-1.3909986

Pichini S., Pacifici R., Marinelli E., Busardò F.P. European drug users at risk from illicit fentanyls mix. Front. Pharmacol. 2017;8:785. PubMed PMC

EMCDDA . European Drug Report - Trends & Development 2017. Luxembourg: Publications Office of the European Union; 2017.

The European Parliament and The Council of the European Union 2017.

The European Parliament and The Council of the European Union 2017.

EMCDDA . European Drug Report - Trends & Developments 2013. Luxembourg: Publications Office of the European Union; 2013.

Scientific Working Group for the Analysis of Seized Drugs SWGDRUG Home Page Available on. http://swgdrug.org/

Chemicals C. Cayman Spectral Library Available on. https://www.caymanchem.com/forensic/csl

https://www.designer-drugs.de/

Smith J.P., Sutcliffe O.B., Banks C.E. An Overview of recent developments in the analytical detection of new psychoactive substances (NPSs). Analyst (Lond.) 2015;140:4932–4948. PubMed

Shevyrin V., Melkozerov V., Nevero A., Eltsov O., Shafran Y., Morzherin Y., Lebedev A.T. Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a n-1-methoxycarbonylalkyl group. Anal. Bioanal. Chem. 2015;407:6301–6315. PubMed

Adamowicz P., Tokarczyk B. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry. Drug Test. Anal. 2016;8:652–667. PubMed

Kanu A.B., Brandt S.D., Williams M.D., Zhang N., Hill H.H. Analysis of psychoactive cathinones and tryptamines by electrospray ionization atmospheric pressure ion mobility time-of-flight mass spectrometry. Anal. Chem. 2013;85:8535–8542. PubMed

Uchiyama N., Kawamura M., Kikura-Hanajiri R., Goda Y. URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci. Int. 2013;227:21–32. PubMed

Uchiyama N., Asakawa K., Kikura-Hanajiri R., Tsutsumi T., Hakamatsuka T. A new pyrazole-carboxamide type synthetic cannabinoid ab-chfupyca [n-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1h-pyrazole-5-carboxamide] identified in illegal products. Forensic Toxicol. 2015;33:367–373. PubMed PMC

Shevyrin V., Kupriyanova O., Lebedev A.T., Melkozerov V., Eltsov O., Shafran Y., Morzherin Y., Sadykova R. Mass spectrometric properties of n-(2-methoxybenzyl)-2-(2,4,6-trimethoxy-phenyl)-ethanamine (2,4,6-tmpea-nbome), a new representative of designer drugs of NBOMe series and derivatives thereof. J. Mass Spectrom. 2016;51:969–979. PubMed

Concheiro M., Castaneto M., Kronstrand R., Huestis M.A. Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching. J. Chromatogr. A. 2015;1397:32–42. PubMed PMC

de Castro A., Lendoiro E., Fernández-Vega H., Steinmeyer S., López-Rivadulla M., Cruz A. Liquid chromatography tandem mass spectrometry determination of selected synthetic cathinones and two piperazines in oral fluid. Cross reactivity study with an on-site immunoassay device. J. Chromatogr. A. 2014;1374:93–101. PubMed

Gaspar H., Bronze S., Ciríaco S., Queirós C.R., Matias A., Rodrigues J., Oliveira C., Cordeiro C., Santos S. 4F-PBP (4′-Fluoro-α-Pyrrolidinobutyrophenone), a new substance of abuse: Structural characterization and purity NMR profiling. Forensic Sci. Int. 2015;252:168–176. PubMed

Langer N., Lindigkeit R., Schiebel H-M., Ernst L., Beuerle T. Identification and quantification of synthetic cannabinoids in “spice-like” herbal mixtures: A snapshot of the German situation in the autumn of 2012. Drug Test. Anal. 2014;6:59–71. PubMed

Acton W.J., Lanza M., Agarwal B., Jürschik S., Sulzer P., Breiev K., Jordan A., Hartungen E., Hanel G., Märk L., Mayhew C.A., Märk T.D. Headspace analysis of new psychoactive substances using a selective reagent ionisation-time of flight-mass spectrometer. Int. J. Mass Spectrom. 2014;360:28–38. PubMed PMC

Strano R.S., Odoardi S., Gregori A., Peluso G., Ripani L., Ortar G., Serpelloni G., Romolo F.S. An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials. Rapid Commun. Mass Spectrom. RCM. 2014;28:1904–1916. PubMed

Bell C., George C., Kicman A.T., Traynor A. Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Test. Anal. 2011;3:496–504. PubMed

Guirguis A., Girotto S., Berti B., Stair J.L. Identification of new psychoactive substances (NPS) using handheld raman spectroscopy employing both 785 and 1064nm Laser Sources. Forensic Sci. Int. 2017;273:113–123. PubMed

Namera A., Kawamura M., Nakamoto A., Saito T., Nagao M. Comprehensive review of the detection methods for synthetic cannabinoids and cathinones. Forensic Toxicol. 2015;33:175–194. PubMed PMC

Valente M.J. Guedes, de Pinho P.; de Lourdes, B.M.; Carvalho, F.; Carvalho, M. Khat and synthetic cathinones: A review. Arch. Toxicol. 2014;88:15–45. PubMed

Slovenian Ministry of the Interior https://www. policija.si/eng/index.php/generalpolicedirectorate/1669-nfl-page-response

Lobo Vicente J., Chassaigne H., Holland M.V., Reniero F., Kolář K., Tirendi S., Vandecasteele I., Vinckier I., Guillou C. Systematic analytical characterization of new psychoactive substances: A case study. Forensic Sci. Int. 2016;265:107–115. PubMed

Weininger D. SMILES, a Chemical Language and Information System. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Model. 1988;28:31–36.

Frey J.G. The IUPAC International Chemical Identifier: Using InChi. Chem. Int. 2006:14–15.

McNaught A. The IUPAC International Chemical Identifier: InChi - a new standard for molecular informatics. Chem. Int. 2006;•••:12–14.

Heller S., McNaught A., Stein S., Tchekhovskoi D., Pletnev I. InChI - the Worldwide Chemical Structure Identifier Standard. J. Cheminform. 2013;5:7. PubMed PMC

Heller S.R., McNaught A., Pletnev I., Stein S., Tchekhovskoi D. InChI, the IUPAC International Chemical Identifier. J. Cheminform. 2015;7:23. PubMed PMC

OPSIN Open Parser for Systematic IUPAC Nomenclature Available on. http://opsin.ch.cam.ac.uk/

Lowe D.M., Corbett P.T., Murray-Rust P., Glen R.C. Chemical name to structure: Opsin, an open source solution. J. Chem. Inf. Model. 2011;51:739–753. PubMed

https://chemaxon.com/products/chemicalize

Zanzi A., Wittwehr C. Searching online chemical data repositories via the chemagora portal. J. Chem. Inf. Model. 2017;57:2905–2910. PubMed

Archer R.P., Treble R., Williams K. Reference materials for new psychoactive substances. Drug Test. Anal. 2011;3:505–514. PubMed

EMCDDA http://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids

Reniero F., Lobo P.V.J., Chassaigne H., Holland M., Tirendi S., Kolar K., Guillou C. Report on Characterisation of New Psychoactive Substances (NPS); EUR - Scientific and Technical Research Reports. Publications Office of the European Union; 2014.

DG TAXUD-CLEN https://ec.europa.eu/taxation_ customs/business/customs-controls/eu-customs-laboratories/customs-laboratories-eu-network-overview/action-1-group-eu-customs-laboratories_en

https://ec.europa.eu/ taxation_customs/sites/taxation/files/nmr_iliade.pdf

https://ec.europa.eu/ taxation_customs/sites/taxation/files/hr_iliade.pdf

https://ec.europa.eu/taxation_customs/sites/taxation/files/gcms_iliade.pdf

https://ec.europa.eu/ taxation_customs/sites/taxation/files/ftir_iliade.pdf

Slovenian Ministry of the Interior https://www.policija.si/apps/nfl_response_ web/seznam.php

Buback M., Kuelpmann A. A suitable photoinitiator for pulsed laser-induced free-radical polymerization. Macromol. Chem. Phys. 2003;204:632–637.

2017.

Europan Commission - DG Taxation and Customs Union (TAXUD) European Customs Inventory of Chemical Substances Available on. https://ec.europa.eu/taxation_customs/online-services/eu-customs-inventory-chemical-substances_en

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...